Key Drivers and Opportunities in the Type 2 Diabetes Market: Insights into Trends and Growth
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Future CAGR of the Type 2 Diabetes Market, and How Will It Impact Industry Expansion?
Over the past few years, there has been a substantial growth in the market size of type 2 diabetes. The estimate projects a rise from $48.14 billion in 2024 to $51.96 billion in 2025, which indicates a compound annual growth rate (CAGR) of 7.9%. Factors such as changes in lifestyle and diet, aging population, advancements in pharmaceuticals, and public health initiatives fuelled the growth during the historic period.
The market size for type 2 diabetes is predicted to experience robust expansion over the upcoming years. It is set to reach $72.22 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.6%. The growth during the forecast period is due to factors such as the worldwide diabetes epidemic, personal medication advancements, evolution in technology, and modifications in healthcare policies. Noteworthy trends during this forecast period consist of digital health and telemedicine, proactive prevention and early intervention measures, the usage of artificial intelligence (AI) and machine learning (ML), and metabolic surgery.
What External and Internal Drivers Are Contributing to the Growth of the Type 2 Diabetes Market’s Growth?
The projection of the type 2 diabetes market is set to expand, primarily driven by the escalating rates of obesity and heart disease. Obesity, a health condition marked by excessive body fat levels, and heart disease, a term encompassing a variety of heart and blood vessels-related conditions, are becoming prevalent. Overweight individuals are at higher risk of insulin resistance, which can cause elevated blood sugar levels, thus triggering the development of type 2 diabetes. Conversely, high blood sugar levels can inflict damage upon blood vessels and nerves controlling the heart and blood vessels, leading to heart ailments. For instance, in March 2024, the World Health Organization (WHO), a Swiss-based intergovernmental entity, revealed that about one-eighth of the global population were grappling with obesity. This comprised 2.5 billion overweight adults who are 18 years and above, with 890 million of them suffering from obesity. Among these adults, 43% were overweight, and 16% were categorized as obese. Moreover, the count of overweight children aged under 5 hit 37 million. Hence, the rising incidences of obesity and heart disease are stimulating the growth of the type 2 diabetes market.
Type 2 Diabetes Market Driver: Surge in Elderly Population Fuels Type 2 Diabetes Market Expansion
Request Your Free Type 2 Diabetes Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13050&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Type 2 Diabetes Market?
Major companies operating in the type 2 diabetes market are:
• F. Hoffmann-La Roche AG_x000D_
• Merck and Co. Inc._x000D_
• Novartis AG_x000D_
• AstraZeneca PLC_x000D_
• Abbott Laboratories_x000D_
What Key Market Trends Are Shaping the Future of the Type 2 Diabetes Industry?
Leading firms immersed in the type 2 diabetes industry are innovating with new products like Mounjaro, aiming to elevate safety and efficacy for patients with diabetes. The objective of these trailblazing medications such as Mounjaro is to improve the effectiveness, safety, and manageability of diabetes treatment compared to traditional drugs. The creative evolution in diabetes medication formulation concentrates on enhancing blood glucose management, reducing potential side effects, and tackling other related health issues. To illustrate, in May 2022, the U.S. Food and Drug Administration granted approval to Eli Lilly and Co., a pharmaceutical organization based in the U.S., for their Mounjaro (tripeptide) injection designed to upgrade blood glucose control in adults with type 2 diabetes, in tandem with diet and physical exercise. Tirzepatide positions itself as a fresh, dual-action treatment for type 2 diabetes. Administered weekly through an injection, it impacts two hormones responsible for the regulation of blood sugar levels, namely glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). While GLP-1 amplifies insulin production and reduces glucagon production, GIP enhances insulin production. Therefore, Tirzepatide stands as a hopeful new treatment pathway for individuals with type 2 diabetes, even those who have failed to see benefits from previous treatments.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/type-2-diabetes-global-market-report
Which Key Segments Define the Structure of the Type 2 Diabetes Market and Their Growth Potential?
The type 2 diabetes market covered in this report is segmented –
1) By Drug Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Thiazolidinediones, Alpha-Glucosidase Inhibitors, Sulfonylureas And Other Insulin Secretagogues, Biguanides, SodiumGlucose Cotransporter 2 Inhibitors, Other Drug Classes
2) By Application: Glycemic Control, Cardiovascular Safety, Hypoglycemia Avoidance, Other Applications
3) By End-User: Children, Adults
Subsegments:
1) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
2) By Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists: Liraglutide, Semaglutide, Dulaglutide, Exenatide
3) By Thiazolidinediones: Pioglitazone, Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
5) By Sulfonylureas And Other Insulin Secretagogues: Glimepiride, Glipizide, Glyburide
6) By Biguanides: Metformin
7) By Sodium-Glucose Cotransporter 2 Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin
8) By Other Drug Classes: Amylin Analogues, Bile Acid Sequestrants, Dopamine Agonists
Which Geographical Regions Are Shaping the Type 2 Diabetes Market Growth?
North America was the largest region in the type 2 diabetes market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in type 2 diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Scope and Reach of the Type 2 Diabetes Market Defined?
Type 2 diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels due to insulin resistance and inadequate insulin production. The development of Type 2 diabetes is influenced by a combination of genetic, lifestyle and environmental factors. Dietary and pharmaceutical adjustments can manage type 2 diabetes by lowering weight, eating a healthy diet and exercising consistently.
Browse Through More Similar Reports By The Business Research Company:
Pet Diabetes Care Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pet-diabetes-care-global-market-report
Smart Insulin Pens Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report
Artificial Intelligence in Diabetes Management Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
